ANAPA BIOTECH A/S: Financial statements 2021
CVR: 27585167
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
ANAPA BIOTECH A/S (CVR 27585167) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK 1,011,604 and a net result of DKK 612,196 compared with DKK 472,071 the year before. That is an increase of 92.4% compared with the year before. Equity in the 2021 report amounted to DKK 1,084,267. The solvency ratio was 52.3%.
- Gross Profit
- DKK 1,011,604
- Profit/Loss
- DKK 612,196
- Equity
- DKK 1,084,267
- Total Assets
- DKK 2,073,972
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | 1M | 612K | 1.1M | - |
| 2020 | - | 526K | 472K | 472K | 1 |
| 2019 | - | 104K | -3.8M | 0 | 1 |
| 2018 | - | 236K | -693K | 3.8M | 1 |
| 2017 | - | 360K | -5.2M | 4.5M | 1 |
Official annual report
Find more companies like ANAPA BIOTECH A/S
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorEvents in 2021
ANAPA BIOTECH A/S has published its annual report for 2020. Gross profit came to DKK 525,854, and the net result was DKK 472,071.
About ANAPA BIOTECH A/S
ANAPA BIOTECH A/S is a Danish company of the type Aktieselskab based in Hørsholm, founded in 2004. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named QUANTIBACT A/S and LNA BACTERIAL DETECTION A/S. The management consists of Søren Morgenthaler Echwald. The board consists of Anette Kofod Echwald (chair), Caroline Marie Morgenthaler Echwald and Søren Morgenthaler Echwald. The company is owned by Apana Holding ApS. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 263,027 and a net result of DKK 488,982 compared with DKK 7,646,635 the year before. Equity in the 2025 report amounted to DKK 10,970,173.
